RTX (RTX) Q3 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 23/24 earnings summary
23 Jan, 2026Executive summary
Q3 revenue increased to DKK 142 million, slightly above revised guidance after a downgrade earlier in the year, driven by late-quarter shipments, but order intake remains below original guidance and visibility is limited.
Gross margin improved sequentially due to supply chain normalization and higher revenue, with cost control measures keeping fixed costs flat.
EBITDA for Q3 was DKK 9 million, reflecting positive trends but still below target and down from DKK 14 million year-over-year.
Management revised full-year outlook downward in June due to postponed orders and lower demand, especially in ProAudio and Enterprise segments.
Financial highlights
Q3 2023/24 revenue: DKK 142 million (down 16% YoY); 9M revenue: DKK 349 million (down 37% YoY).
Q3 EBITDA: DKK 9 million (down from DKK 14 million YoY); 9M EBITDA: DKK -20 million (down from DKK 64 million YoY).
Inventory reduced by DKK 9 million in Q3 and DKK 11 million over nine months, with no obsolete inventory risks.
Net liquidity improved by DKK 13 million in Q3, but down DKK 37 million for the nine months, impacted by negative EBITDA and reduced working capital.
Cash position at end of Q3 was DKK 100 million, up from DKK 91 million year-over-year.
Outlook and guidance
Full-year 2023/24 revenue expected at DKK 500–510 million (previously DKK 580–630 million); EBITDA at DKK 0–10 million (previously DKK 45–60 million); EBIT at DKK -40 to -30 million (previously DKK 5–20 million).
No new guidance for next year until the annual report; visibility remains low with customer forecasts limited to 3–6 months.
Normalization of customer inventory and demand expected over the next 12 months, but timing remains uncertain.
Majority of revenue to come from existing products; up to 20% from new launches.
Gross margin expected to improve sequentially but remain below last year due to lower revenue.
Latest events from RTX
- Revenue up 7% to DKK 108m, with strong Healthcare and ProAudio growth, margin up to 54.9%.RTX
Q1 25/262 Feb 2026 - Revenue up 7% year-over-year, gross margin and liquidity improved, guidance maintained.RTX
Q1 25/2629 Jan 2026 - Revenue up 23% and gross margin at 51%, led by Enterprise; outlook limited by short order horizons.RTX
Q1 24/259 Jan 2026 - Revenue up 10%, gross margin at 50%-51%, EBITDA surged, and outlook remains strong.RTX
Q4 24/2529 Nov 2025 - Double-digit revenue growth and margin expansion achieved, with strong outlook for 2025/26.RTX
Q4 24/2529 Nov 2025 - Strong revenue and margin growth led to raised guidance and a DKK 20m share buyback.RTX
Q3 24/2523 Nov 2025 - Revenue and profit fell significantly amid high inventories and uncertainty; outlook remains cautious.RTX
Q4 23/2421 Oct 2025 - Revenue up 23% and gross margin at 50.8%, but outlook limited by short order cycles.RTX
Q1 24/256 Jun 2025 - Enterprise and Healthcare growth drove strong H1 results, but tariff risks remain.RTX
Q2 24/255 Jun 2025